182 related articles for article (PubMed ID: 23518014)
1. [In vitro susceptibility of vaginal Candida albicans to antifungal drugs in Abidjan (Ivory Coast)].
Djohan V; Angora KE; Vanga-Bosson AH; Konaté A; Kassi FK; Yavo W; Kiki-Barro PC; Menan H; Koné M
J Mycol Med; 2012 Jun; 22(2):129-33. PubMed ID: 23518014
[TBL] [Abstract][Full Text] [Related]
2. Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d'Ivoire).
Konaté A; Yavo W; Kassi FK; Djohan V; Angora EK; Barro-Kiki PC; Bosson-Vanga H; Soro F; Menan EI
J Mycol Med; 2014 Jun; 24(2):93-9. PubMed ID: 24387809
[TBL] [Abstract][Full Text] [Related]
3. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
[TBL] [Abstract][Full Text] [Related]
5. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
8. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
[TBL] [Abstract][Full Text] [Related]
9. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
10. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
11. [Fungi isolated from the vagina and their susceptibility to antifungals].
Macura AB; Skóra M
Ginekol Pol; 2012 Jun; 83(6):433-8. PubMed ID: 22880463
[TBL] [Abstract][Full Text] [Related]
12. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M
BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738
[TBL] [Abstract][Full Text] [Related]
14. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
[TBL] [Abstract][Full Text] [Related]
16. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
17. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
18. Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d'Ivoire): Aetiology and associated factors.
Djohan V; Angora KE; Vanga-Bosson AH; Konaté A; Kassi KF; Kiki-Barro PCM; Bedia-Tanoh AV; Miezan S; Menan EIH; Yavo W
J Mycol Med; 2019 Jun; 29(2):127-131. PubMed ID: 31010729
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
Dorocka-Bobkowska B; Konopka K
Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341
[TBL] [Abstract][Full Text] [Related]
20. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
